The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavity

Read full text
Authors: Shunying Jin, Richa A. Singhal, Jianzhu Luo, Yasmine H. Higgins, Kelley N Cooper, Marina Terekhova, Katherine Carey, Audrey F. Duff, Maxim N. Artyomov, Venkatakrishna Rao Jala, Rachel A. Idol, Michael T. Bailey
+3 more Mary C. Dinauer, Richard J. Lamont, Juhi Bagaitkar
Cited by: 0
References: 58

Abstract

ABSTRACT The leukocyte NADPH oxidase 2 (NOX2) is an important regulator of inflammatory responses, independent of its antimicrobial activity. Inactivating mutations in NOX2 cause chronic granulomatous disease (CGD), a severe immunodeficiency associated with recurrent infections and dysregulated neutrophilic inflammation. Recurrent oral ulcers, stomatitis, gingivitis, and other inflammatory issues affecting the oral mucosa have been observed in patients with CGD; however, the underlying mechanisms are not known. Here, we present evidence that the extensive inflammatory destruction of oral mucosal tissues observed in Nox2-deficient or Cybb KO mice was not caused by impaired antimicrobial surveillance against oral pathobionts but instead resulted from a cell-intrinsic dysregulation of neutrophil inflammatory responses. Transcriptional and cellular profiling of oral tissues isolated from wild-type and Cybb KO mice showed a dominant neutrophil signature, which was accompanied by a significant upregulation of several bone-resorbing, tissue-degrading inflammatory cytokines and a reduced expression of nuclear factor erythroid 2-related factor 2 (Nrf2) regulated genes. Mechanistically, hyperinflammatory responses were mitigated by restoring Nrf2 transcriptional activity using a synthetic agonist. Thus, our studies show that Nox2 oxidase and its derived reactive oxygen species are crucial for balanced recruitment and cell-intrinsic regulation of neutrophil inflammatory responses within oral tissues in an Nrf2-dependent manner.

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Immune Response and Inflammation Blood disorders and treatments

Publication details

Journal / source
Mucosal Immunology
Volume
19
Issue
3
Pages
100341–100341
Publication date
8 April 2026
Language
EN